logo

Inovio Pharmaceuticals Inc. (INO)



Trade INO now with
  Date
  Headline
11/15/2018 8:03:03 AM Inovio Adds Rafi Ahmed To Scientific Advisory Board; Laurent Humeau Named Chief Scientific Officer
11/8/2018 4:10:49 PM Inovio Pharmaceuticals Q3 Loss/share $0.27 Vs. Loss $0.40 Year Ago
10/22/2018 8:05:11 AM Inovio Presents PFS & PSA Doubling Time Improvements In Prostate Cancer Patients Treated With INO-5150
10/15/2018 8:02:53 AM Inovio Says Its Ebola Vaccine Provides 100% Protection And Elicits Long-Lasting Immune Responses In Preclinical Studies
10/8/2018 8:03:10 AM Inovio Develops First DNA-Encoded Monoclonal Antibody Checkpoint Inhibitor And Demonstrates Tumor Shrinkage
10/2/2018 8:15:27 AM Inovio Reports Major Cancer Journal Highlights Data From An Inovio-Sponsored Trial
9/17/2018 8:30:05 AM Inovio Pharma Develops Novel H3N2 Influenza DNA Vaccine; Provides Complete Protection Against Lethal Challenges
9/5/2018 8:01:37 AM Inovio Doses 1st Subject In Phase 1/2 Clinical Trial For Vaccine Against Deadly MERS Infection
9/4/2018 1:03:20 AM Inovio, GeneOne Dose First Patient In Phase 1 Study To Evaluate Preventive Vaccine Against Hepatitis C Infection
8/16/2018 8:02:27 AM Inovio Doses First Patient In Phase 1/2a Study Designed To Evaluate INO-5401
8/14/2018 8:04:17 AM Inovio Says First Participant Dosed With PENNVAX-GP In Randomized Clinical Trial
8/7/2018 4:08:28 PM Inovio Q2 Net Loss $6.6 Mln Or $0.08 Per Share
8/6/2018 8:06:29 AM Inovio Enters Partnership With AIDS Malignancy Consortium To Evaluate VGX-3100
6/27/2018 8:03:10 AM Inovio Announces Positive Phase 1 Results Of Collaborative Vaccine Study With INO-4700 Against MERS